Skip to content

Latissimus Dorsi Flap Reconstructions: Retrospective Study

Latissimus Dorsi Flap Reconstructions: Retrospective Study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06800547
Acronym
PLAST-LD
Enrollment
200
Registered
2025-01-30
Start date
2023-06-21
Completion date
2025-06-30
Last updated
2025-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Surgery

Brief summary

Various options for reconstruction alternatives to LD are described, as are the possible early and late side effects of LD harvesting. Currently, the choice of whether or not to resort to LD harvesting to repair the defect is based on the experience and preference of the specific working group. The importance of the study lies in the attempt to analyze the choices made in the diagnostic and therapeutic phase (demolitive and reconstructive) on patients in order to correlate the outcomes obtained in terms of healing, quality of life and complications in the recipient site and in the donor site.

Detailed description

Currently, there are no universally accepted guidelines regarding when it is advisable to resort to a LD flap for the repair of a large defect and when it is considered contraindicated. Various options for reconstruction alternatives to LD are described, as are the possible early and late side effects of LD harvesting. Currently, the choice of whether or not to resort to LD harvesting to repair the defect is based on the experience and preference of the specific working group. The importance of the study lies in the attempt to analyze the choices made in the diagnostic and therapeutic phase (demolitive and reconstructive) on patients treated at IRCCS Azienda Ospedaliero-Universitaria di Bologna, Policlinico di Sant'Orsola in past years, in order to correlate the outcomes obtained in terms of healing, quality of life and complications in the recipient site and in the donor site with the baseline conditions of the patients, the site and the extension of the defect.

Interventions

None listed

Sponsors

IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Duration of surgery, expressed in minutes; * Hospitalization time, expressed in days; * Need for reoperation within 30 days of the first operation; * Survival and recurrences, based on the last available follow-up

Exclusion criteria

* Incomplete or missing data

Design outcomes

Primary

MeasureTime frameDescription
Technical SuccessFrom the first enrollment, up to the 200th, an average of 2 yearsTechnical success is assessed by: the duration of surgery; days of Hospitalization; need for reoperation within 30 days of the first operation; survival and recurrences, based on the last available follow-up.

Countries

Italy

Contacts

Primary ContactMarco Pignatti, MD
marco.pignatti@unibo.it+390512143614

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026